OBJECTIVE: To investigate whether total body fat mass or fat distribution and associated metabolic disturbances in glucose and lipid metabolism in¯uence the well known gallstone pathogenetic factors in obese subjects in order to explain why some obese subjects develop gallstones and some do not. DESIGN: Cross sectional study of gallstone pathogenetic factors, body composition, fat distribution, glucose and lipid metabolism. SUBJECTS: 57 healthy overweight subjects (aged 26±64 y, body mass index (BMI) 30±45 kg/m 2 ). MEASUREMENTS: Total and intra-abdominal fat masses were measured by dual X-ray absorptiometry and abdominal CT scanning, respectively. The lithogenic index was measured in aspirated bile. The gallbladder volume was determined by ultrasound and the gallbladder ejection fraction% by dynamic cholescintigraphy. Plasma cholecystokinin (CCK) concentrations during a meal were measured with a speci®c radioimmunoassay. Insulin sensitivity was measured by the Minimal Model and glucose tolerance by an oral glucose tolerance test (OGTT). Serum lipid concentrations were measured by standard methods. RESULTS: The gallbladder volume in the fasting state increased with increasing intra-abdominal fat mass (P 0.006) and was increased in subjects with impaired glucose tolerance (41 vs 27 ml, P 0.001). The lithogenic index was b 1 in all subjects and correlated with total fat mass (P 0.04). CONCLUSION: Gallstone pathogenesis in obesity seems to be in¯uenced by the total body fat mass and its regional distribution possibly via mutual association with the glucose tolerance.
Introduction
Obesity, as de®ned by a body mass index (BMI, body weightaheight 2 ) b 30 kgam 2 , is a major risk factor for the formation of gallstones. 1 However, BMI is an indirect measure of obesity, that is more directly expressed by the total body fat mass (FM). Moreover, the distribution of the body fat, as well as the total amount, also have importance. Intraperitoneal fat, draining into the portal vein is part of a metabolic syndrome covering hyperinsulinaemia, insulin resistance, hyperlipidaemia, cardiovascular disease and non insulin dependent diabetes mellitus (NIDDM). 2 Direct measurements of FM and intra-abdominal fat mass have not hereto been related to the risk of gallstone formation.
The question has been raised whether an association exists between diabetes mellitus and gallstone disease. Several studies have found it to be so 3 and, independent of overall obesity, increased blood concentrations of glucose and insulin have also been related to gallstone disease. 4±6 The relation between gallstone disease and hyperlipidaemia has been known for decades and has attracted growing interest, because of the dyslipoproteinaemia and hyperinsulinaemia seen in diabetes and obesity. Multivariate analysis have shown a relation between elevated serum concentrations of triglyceride and low concentrations of HDL cholesterol 7 and gallstone disease, but not usually between total cholesterol 8 and gallstone disease.
The pathogenesis of gallstone disease is probably multifactorial. 9 It involves supersaturated bile, nucleation and growth of cholesterol crystals and impaired gallbladder motor function, with increased gallbladder volume 10 and impaired ejection fraction%. 11 In obese subjects the bile is supersaturated, 12 the volume of the gallbladder in the fasting state is large, 13, 14 and emptying of the gallbladder is often, 14 but not always, 13 reduced. In diabetics without gallstone disease, emptying of the gallbladder is impaired 15 even when checking for obesity, 16 and the bile is supersaturated. 17 Cholecystokinin (CCK) regulates postprandial emptying 18 and, therefore, impaired contractility of the gallbladder might be caused by impaired release or receptor-binding of CCK. So far, no convincing evidence has been reported of a role for CCK in gallstone disease. 10, 14, 19, 20 The aim of the present study was to evaluate if there is any relationship between the dominating pathogenetic factors for gallstone development and body composition or fat distribution. Since obesity and, particularly, abdominal fat distribution is associated with disturbances in glucose and lipid metabolism, gallstone pathogenetic factors were also investigated in relation to these parameters in order to explain why some obese subjects develop gallstones and some do not.
Subjects and methods

Subjects
The study comprised 57 (12 men, 45 women) non diabetic obese subjects without gallstones whose weight was in a steady state. Their mean age was 42 AE 10 y (range 26±64 y), mean body weight 104 AE 14 kg (range 78±143 kg), and BMI 37 AE 4 kgam 2 (range 30±45 kgam 2 ). All the subjects had been obese for several years, but were otherwise healthy as assessed on history, physical examination, routine blood tests, abdominal ultrasound examination and ECG. None were taking any medication known to in¯uence the fat free mass, FM, serum lipids, bile composition, glucose metabolism, gastrointestinal motility or gastrointestinal hormones.
Oral glucose tolerance test (OGTT)
After an overnight fast, blood was taken for measurement of plasma glucose before, and 1 h and 2 h after ingestion of a 75 g oral glucose challenge. Plasma glucose was measured immediately by an automated glucose oxidase method (Glucose Analyzer II, Beckman Instruments, Fullerton, CA, USA). Glucose tolerance was classi®ed as: normal, impaired or NIDDM, according to the WHO criteria. 21 
Insulin sensitivity
The minimal model procedure modi®ed with tolbutamide 22 was used to calculate the insulin sensitivity index (S I ).
After an overnight fast, the subjects were given a glucose load of 0.3 gakg intravenously over 60 s, followed 20 min later by injection of 300 mg tolbutamide.
Blood was taken at 2, 4, 6, 8, 10, 12, 16, 19, 22, 25, 30, 40, 50, 70, 90, 135 and 180 min for immediate determination of glucose and later for plasma insulin measurements. In addition, three baseline samples were taken 15, 10 and 5 min before the glucose injection. Insulin was determined by an enzyme-linked two-site immunoassay 23 and glucose was measured as described above.
The data were analysed by means of the MINIMOD computer programme (version 2.1. 1994) supplied by R. N. Bergman. 24 This programme accepts as input, the temporal pattern of plasma insulin, and then ®ts a simple (minimal) model of insulin-dependent utilisation of glucose, to the measured glucose pattern. Sensitivity to insulin (S I ) can be calculated from the model parameters emerging from the ®t. S I is given as min
71
/mU/ml and expresses how much a unit increment in insulin concentration will enhance the fractional disappearance of plasma glucose. 25 Dual X-ray absorptiometry (DXA) scanning DXA measurements were performed with a Norland XR-36 densiometer (Norland Corporation, Fort Atkinson, WI, USA). This apparatus has an X-ray tube, which operates at 100 kV, samarium ®ltration (K edge 46.8 keV), which produces energy peaks at maxima of 40 and 80 keV, and a dual NaI detector assembly. The samarium ®ltration is changed dynamically during the scan, to reduce beam hardening effects. This is done by interposing a varying number of samarium ®lter sheets, depending on the actual absorber thickness, whereby the intensity of the radiation beam tends to become uniform over a large range of tissue thicknesses. The spatial resolution is 6.5 6 13.0 mm 2 (pixel size). The entry dose of a 20 min whole body scan is less than 1.0 mSv.
Software version 2.4 was used for data acquisition and analysis. 6 The subjects lay supine on the scan table with their arms as close as possible to the trunk and their legs as close together as possible.
The variables calculated from the DXA scan were fat free mass and FM. Fat free mass was calculated as the sum of the total body mineral content and the lean soft tissue mass. The accuracy of the DXA method was validated by 40 K measurements of the total body potassium, as described previously. 27 
Computed tomography scanning
Abdominal CT scanning was performed with a General Electric 9800 CT scanner (GE Medical Systems, Milwaukee, WI, USA). Scanning was performed at 140 kV, 170 mA, 3 s, with a slice thickness of 10 mm. The subjects were examined with arms stretched over their heads in order to minimise artifacts. The slices selected for measurement were located by the following skeletal landmarks: the levels of Th 8 ± Th 9 , Th 12 ± L 1 , L 4±5 , the caudal edge of the sacro-iliac joint and the proximal edge of the symphysis. Areas of adipose tissue on each cross-sectional image were calculated by masking and counting the voxels within the de®ned Houns®eld unit range of 730 to 7190 HU (standard software option). The areas of intra-abdominal (intraperitoneal) tissue were differentiated by encircling the abdominal muscular wall to get the area of subcutaneous adipose tissue and then subtracting this area from the total area of adipose tissue. The distances between the slices were measured in order to calculate the intra-abdominal fat volume from the Th 9 level to the proximal edge of the symphysis. 28 To convert the volumes of adipose tissue into weight, the density of triglycerides in human adipose tissue at 37 C 0.9 g/ cm 3 , was used. 29 When the patient was larger than the ®eld of view (diameter 48 cm) truncated artifacts appeared causing increased Houns®eld units near the outer edge of the reconstructed image. We coped with this problem by placing the patient asymmetrically in the gantry so that half the trunk was visualised and the proper values were obtained. The area of interest (half the trunk) was then multiplied by two. The entry dose of a serial scan was 5 mSv.
Serum lipid concentrations
Venous blood samples after an overnight fast were taken for measurements of the serum total cholesterol, serum triglyceride, VLDL cholesterol and HDL cholesterol. Analyses were performed by Medi-Lab, Copenhagen, Denmark, in accordance with the laboratory's standard methods.
Dietary fat
The subjects were asked to weigh all their food and ®ll in a food diary for four days (two week-end days included). The total fat and total cholesterol were calculated with a national computer programme (Dankost 2, Danisk Catering Centre, WHO Collaborating Centre for Nutrition in Mass Catering, Copenhagen, Denmark (www. Dankost.dk for more information).
Lithogenic index
After an overnight fast, bile was collected through a nasoduodenal tube (Radiopaque polyvinyl chloride closed end Bilbao-Dotter hypotonic duodenography catheter, William Cook Europe aas, Bjaeverskov, Denmark) positioned under¯uoroscopy (Siemens Klinograph 2: the X-ray dose was 0.1 mSvamin) in the second part of the duodenum. CCK-8 (Kinevac, E. R. Squibb and Sons, Princeton, NJ, USA) 0.01 mgakg, was infused over 10 min to induce contraction of the gallbladder.
Bile-rich¯uid was aspirated from the duodenum over a 30 min period and the samples were immediately stored at 720 C until analysed. The concentration of cholesterol was determined with the Cholesterol Kit (BoeringeraMannheim, Mannheim, Germany) at 405 nm on a spectrophotometer (Beckman 25, Beckman Instruments, Fullerton, CA, USA). 30 The concentration of bile acid was determined with an enzymatic kit (Sterognost 3-alfa-Pho, Nycomed DAK, Copenhagen, Denmark). The bile was diluted with sterile NaCl 1 : 6 and centrifuged at 3000 g/min for 10 min and bile acid content was determined by spectrophotometer (Shimadzu UV160A, Kyoto, Japan) at 340 nm. 31 The phospholipid concentration was measured by the enzymatic method described by Gurantz and Hoffmann. 31 The bile sample was diluted with isopropanol 1 : 9 and centrifuged at 3000 gamin for 10 min, after which the phospholipid concentration was determined by the Beckman spectrophotometer at 505 nm. Lithogenic indices were calculated from the critical tables of Carey. 32 
Fasting gallbladder volume
After an overnight fast, a trained investigator (LH) determined the volume of the gallbladder by ultrasonography throughout the morning with a mechanical sector scanner 3.5 MHz (Siemens Sonoline SL-2, Erlangen, Germany) with a modi®ed Simpson's method. 33 The presence or absence of gallbladder stones and sludge was noted.
CCK-8 Stimulated gallbladder ejection fraction%
After fasting, the subjects were placed in a supine position under a gamma camera (Orbiter 2LC 7500, Siemens, Erlangen, Germany) with a 140 keV low energy all purpose parallel hole collimator. The detector was placed anteriorly over the right hypochondriun to achieve visualisation of the liver, gallbladder, bile ducts and upper small intestine. The camera was connected to a computer (Micro Data, Siemens) that allowed simultaneous acquisition of data. Count rates were recorded continuously with one frame/min (CPM). Data acquisition was started at time 0 during administration of a bolus injection of MBq 100 99m Tc-EHIDA (diethylphenylcarbamoylmethyl-iminoacetate, Amersham, UK). Recordings were taken continuously for 60 min. At time 60 min, CCK-8 (Kinevac) 0.3 ngakgamin was infused for 60 min by infusion pump (Ole Dich Instrument Maker, Hvidovre, Denmark). Recordings and CCK-8 infusion were terminated at 120 min.
When the data had been collected, images were replayed from the computer and the time-activity curves for the gallbladder region, corrected for background and radioactive decay, were generated. The maximum gallbladder ejection fraction% from time 60 to time 120 min was calculated as gallbladder ejection fraction% (max CPM 60±120 min 7 min CPM 60±120 min 6 100amax CPM (60±120 min)). 34 The dose of 100 MBq Tc-EHIDA has an effective dose equivalent to 0.024 mSvaMBq, which gives an effective dose equivalent to 2.4 mSv.
Meal stimulated CCK release
After fasting overnight, the subjects ingested a standardised meal containing 37.5 g fat, 30 .0 g protein and 38.7 g carbohydrate (Danish open sandwiches and milk). Five minutes before the meal and 5, 10, 20, 30, 40, 50, 60, 120 and 150 min postprandially, blood was collected in ice-chilled tubes containing 3.9 mmol of EDTA (ethylenediaminetetra-acetate) per ml of blood. Within 1 h, samples were centrifuged (3000 g, 10 min) at 4 C and the plasma was stored at 720 C. Plasma CCK concentrations were measured by a highly speci®c radioimmunoassay with a new antiserum, Ab. 92128, that requires both tyrosyl sulphation and phenylalanyl carboxyamidation of the C-terminal epitope of CCK. Cross-reactivity with sulphated gastrins is less than 0.2%. No other substances have been found to bind to Ab. 92128 (JF Rehfeld, Accurate measurements of cholecystokinin in plasma. Clin Chim 1988; in press). Except for the new antiserum, all reagents and procedures for the CCK assay were as described by Cantor. 35 The following CCK variables were calculated: CCK basal , area under the curve (AUC), integrated increment (AUC 7 CCK basal ). Maximum CCK level and the time taken to reach it were read from the curves.
Study protocol
Body weight, height, FM and %FM were measured on the same day, as were the volume and the ejection fraction% of the gallbladder. OGTT, minimal model, CCK measurements, bile aspiration and abdominal CT scans, were performed on separate days. Blood for determination of serum lipids was taken before starting the minimal model procedure. The subjects ®nished all the tests within a month under weightstable conditions.
Ethics
Before entering the study, all participants were informed about the nature and purpose of the study and all gave their informed consent. The study protocol was approved by the Ethical Committee for Copenhagen and was carried out in accordance with the Helsinki II Declaration of 1975 as amended in 1983. The patient data ®le was approved by the Danish Data Protection Agency.
Statistical analysis
Microsoft Excel Version 5.0 (Microsoft Corp., Redmond, WA, USA) and Statgraphics Plus Version 7 (Manugistics Inc., Rockville, MD, USA) were used for statistical calculations.
Results
The data on the body composition and the gallstone pathogenetic factors are presented in Table 1 , where the subjects are grouped according to their glucose tolerance. Mean results for the whole group are given in the text.
The correlation matrix presented in Table 2 is based on data from the whole group of patients.
Body composition and fat distribution
The mean BMI was 37 AE 4 kgam 2 (n 57). The mean FM was 49 AE 5 kg (29±57 kg) and %FM 48 AE 7 (30± 57 kg) (n 49). The mean intra-abdominal fat mass was 5 AE 2 kg (2±10 kg) (n 49).
Oral glucose tolerance test (OGTT)
Glucose tolerance was normal in 39 subjects (eight of them men) and impaired in 12 subjects (three men). Six subjects (one man) did not show up for the OGTT. Normotolerant subjects did not differ from subjects with impaired glucose tolerance in BMI, weight, FM, %FM, intra-abdominal fat mass, baseline blood glucose, serum insulin or lipid pro®le. S I was impaired in the subjects with impaired glucose tolerance (P 0.045). The subjects who did not participate in the OGTT did not differ from the tested subjects with respect to body composition, fat distribution or gallstone pathogenetic factors and were therefore included in the study as a`not done' subgroup (Table 1) .
Insulin sensitivity (S I )
The mean insulin concentration was 15.5 AE 8.7 mU/l in the whole group of subjects and 17.2 AE 11.6 U/l in six subjects who were not tested for glucose tolerance. The insulin concentrations did not differ signi®cantly between the groups. The subjects were divided arbitrarily into four groups according to their S I values: (1) normal insulin sensitivity (S I 1±5 min 71 amUaml), (2) mild insulin resistance, (3) moderate resistance and (4) There were no signi®cant differences between the insulin sensitive and the insulin resistant group in total body fat mass, %FM, intra-abdominal fat mass, serum lipid pro®le, dietary fat intake or gallstone risk factors.
Serum lipid concentrations
The mean serum concentrations were found to be as follows: Total cholesterol: 5.5 AE 1.3 mmolal; HDL cholesterol: 1.2 AE 0.3 mmolal; VLDL cholesterol: 0.8 AE 0.5 mmolal; LDL cholesterol: 3.4 AE 1.1 mmola l; and triglyceride: 1.7 AE 1.1 mmolal. All the mean concentrations were within the reference limits and no differences were found between the subjects with normal and impaired glucose tolerance.
Dietary fat
The total dietary fat content was 102 AE 30 g and the total dietary cholesterol content was 358 AE 167 mg, which did not differ between the subjects with normal, and those with impaired, glucose tolerance.
Lithogenic index (LI)
The mean LI was 2.6 (range 1.0±3. 8) , that is, all the subjects had bile supersaturated with cholesterol 1) . The LI of two subjects with impaired glucose tolerance did not differ from that of the normotolerant subjects (Table 1) . When the data on the subjects with normal and impaired glucose tolerance were pooled, simple linear regression showed that the LI correlated with FM (r 0.66, P 0.04, n 20), serum concentrations of VLDL cholesterol (r 70.55, P 0.01, n 19), baseline concentration of glucose (r 70.49, P 0.04, n 22), and time of maximum CCK concentration (T max ) (r 0.65, P 0.02, n 17) ( Table  2 ).
The variables, that correlated with LI in the simple linear regression (FM, VLDL, blood glucose) were included as covariables in a multiple regression model with the LI as the dependent variable in order to identify which of them that explained the variation in the LI. The FM was the only covariable to remain statistically signi®cant in this model (P 0.004, n 18). Figure 1 shows LI plotted against FM.
Fasting gallbladder volume
The mean volume of the gallbladder in the fasting state was 30 AE 12 ml. None of the subjects had sludge.
When divided according to the results of the OGTT, the gallbladder volumes were 40 ml and 27 ml in the subjects with normal and impaired glucose tolerance, respectively (P 0.001) (Figure 2) .
Simple linear regression analysis showed that the gallbladder volume correlated with the intra-abdominal fat mass (r 0.51, P 0.006, n 41), 2 h blood glucose (r 0.36, P 0.02, n 43), serum LDL cholesterol (r 70.39, P 0.008, n 45), and serum total cholesterol (r 70.31, P 0.04, n 45) ( Table 2 ). These variables were included as covariates in a multiple regression model with the gallbladder volume as the dependent variable in order to identify which of them explained the variation in the gallbladder volume. The intra-abdominal fat mass was the only covariate to remain statistically signi®cant in this model (P 0.0007, n 38). Figure 3 shows the gallbladder volume plotted against the intra-abdominal fat mass.
Gallbladder ejection fraction%
The mean ejection fraction% of the gallbladder was 62 AE 27%. No difference was found between the subjects with normal, and those with impaired, glucose tolerance (Table 1) .
Simple linear regression analysis showed that the gallbladder ejection fraction% did not correlate with body composition, fat distribution, glucose or lipid metabolism (Table 2) .
With respect to other gallstone risk factors, no correlations were found between the gallbladder ejection fraction% and CCK variables, gallbladder volume or the LI (Table 2) .
Meal stimulated CCK release
The mean concentrations of plasma CCK in the fasting state was 0.2 AE 0.3 pM, the mean AUC was 478 AE 325 pMamin, and the mean integrated increment, calculated as AUB 7 baseline, 449 AE 310 pMamin. The mean T max was 112 AE 35 min and the mean C max 5.8 AE 4.7 pM. There were no differences between the subject with normal and those with impaired glucose tolerance (Table 1) . Simple linear regression analysis showed that the baseline concentration of CCK, and the AUC correlated with the total concentration of cholesterol in serum (r 0.51, r 37, respectively, with n 35). Furthermore the baseline concentration of CCK and AUC correlated with the concentration of LDL (r 0.51 and r 0.35, respectively, n 35) and the baseline concentration of CCK correlated with the concentration of insulin (r 0.48, n 35). The time to reach maximum CCK concentration correlated with the insulin level (r 0.45, n 35, P 0.007) and the concentration of glucose 2 h after the glucose challenge (r 0.36, n 39, P 0.025).
In a multiple regression analysis neither the concentration of insulin, cholesterol or LDL, could explain the variation in the baseline CCK concentration, and the variation in ACU could not be explained by the concentrations of cholesterol or LDL. Accordingly, the variation in the time to reach maximum CCK concentration was not explained by the concentration of insulin or blood glucose 2 h after the glucose challenge when these were included as covariables in a multiple regression model.
With respect to correlations between CCK response variables and the other gallstone pathogenic factors, we found a correlation between the LI and T max (r 0.65, P 0.02, n 17), but not between the LI and other CCK parameters, or between the CCK concentrations and either the gallbladder volume or the gallbladder ejection fraction%.
One patient was excluded because of very high baseline' concentrations of CCK (3.9 and 3.5 pmol/l), which suggested that the patient was not fasting.
Discussion
The present study was the ®rst to demonstrate a relation between direct measurements of FM, fat distribution and gallstone pathogenic factors in obesity. Furthermore, an association between gallstone pathogenetic factors and glucose tolerance was demonstrated.
In all our obese subjects, the bile was supersaturated with cholesterol and the LI ranged from 1.0±3.8. It is well known that in obesity the bile is often supersaturated, and with the use of anthropometric measurements, FM has been estimated and shown to be responsible for this association. 36 With the direct measurements of FM by DXA, the present study clearly demonstrated the correlation between FM and the LI. Since the LI did not correlate with body weight, the BMI or %FM, these measurements might be poor indicators of FM in obesity. The lack of an association between body weight and the LI in obesity has also been demonstrated by others. 37 Over a wide range of body weights, the synthesis of cholesterol has been shown to increase stepwise with increasing body weight 38 and with increasing amounts of excess body weight 39 caused by the increased activity of the rate limiting enzyme HMG CoA reductase 40 which may explain the present ®nding. The LI has also been shown to increase with increasing dietary fat. 38 This was not con®rmed in the present study.
The gallbladder volume in the fasting state was larger among the subjects with impaired glucose tolerance than in the normotolerant subjects, and the volume correlated strongly with the intra-abdominal fat mass in a multiple regression analysis. The gallbladder volume has been shown to be enlarged in (overall) obesity, 13,14,41±43 however only a few studies have been published on gallstone disease (prevalence) and fat distribution. In these the waist-tohip ratio 3, 44 and skinfold thickness 45±47 were used as indirect measurements of fat distribution and the conclusions were con¯icting. Furthermore, some studies have shown an association between coronary heart disease 48±50 or coronary risk factors 51 and gallstone disease. As coronary heart disease is associated with intra-abdominal fat mass, which is associated with NIDDM, 2 these studies are in accordance with our results which show that the gallbladder fasting volume correlated with the intra-abdominal fat mass and the glucose tolerance. Theoretically this association could be explained by the following sequence: From intra-abdominal fat accumulation follows impaired glucose tolerance and some sort of subclinical neuropathy that leads to enlarged gallbladder volume. The delayed CCK peak in the patients with impaired glucose tolerance suggest delayed gastric emptying, which further supports the theory of subclinical neuropathy. In the present study there was a (non signi®cant) trend to higher intra-abdominal fat among the subjects with impaired glucose tolerance (4.8 AE 1.4 and 6.4 AE 2.5 kg intra-abdominal fat, respectively) supporting this mutual association between gallbladder volume, glucose tolerance and intra-abdominal fat mass. However, the mechanisms for the correlations might be independent of each other as some studies have shown an association between impaired glucose tolerance and gallstones, independent of obesity level. 4, 52 The lack of association between BMI and gallbladder volume may be explained by the narrow BMI range on which our subjects were recruited, since normal weight subjects were not included. Previous studies have demonstrated increased gallbladder volume in obese subjects compared to normal weight subjects. 13, 14 ,41±43 This is not in disagreement with out ®ndings if the subjects in these studies are regarded as belonging to three subgroups: (1) obese subjects with intra-abdominal fat accumulation, (2) obese subjects without intra-abdominal fat accumulation and (3) normal weight subjects without intraabdominal fat accumulation. Because the gallbladder volume is increased in the subgroup of obese subjects with intra-abdominal fat accumulation, the whole group of obese subjects have larger mean gallbladder volume than the normal weight subjects.
The gallbladder ejection fraction% was not in¯u-enced by body composition, which is in line with some, 13, 53 but not all, studies. 14, 42 Nor was gallbladder motility in¯uenced by glucose metabolism in our non-diabetic population. This could be expected, as decreased emptying of the gallbladder has been described only in subjects suffering from diabetes. 16, 54 In conclusion, two important factors in the gallstone pathogenesis, LI and gallbladder volume, were in¯u-enced by obesity as LI increases with FM and as gallbladder volume increases with increasing intraperitoneal fat accumulation. Furthermore the volume of the gallbladder was larger in subjects with impaired tolerance compared to subjects with normal glucose tolerance. The largest volume was found among the subjects with impaired glucose tolerance and marked accumulation of intra-abdominal fat. Obesity is a major risk factor for gallstone development. The present study suggests that the risk is further increased in obese subjects with abdominal fat distribution.
